Migrant care workers trapped by unfair repayment clauses
Migrant care workers are being exploited through excessive repayment clauses, forcing them to stay in poor working conditions, according to the Royal College of Nursing (RCN). Calls to the RCN’s advice line on this issue have surged from 12 in 2020 to 110 in 2024. Some employers demand tens of thousands from workers who try to leave.
The RCN urges the government to act on Labour’s pre-election promise to investigate these clauses. In addition, they should reform visa rules that limit job changes to 60 days. Without urgent action, hundreds more care workers could face financial and workplace exploitation.
Tariffs impact consumer spending and business strategy
Rising tariffs are causing financial concerns for consumers, leading many to change their shopping habits. A Numerator survey found that 80% of consumers worry about tariff effects, with 75% planning to adjust spending. Two in five shoppers seek discounts as prices rise, while one-third plan to buy fewer imports.
Mario Matulich of Customer Management Practice says businesses must focus on customer experience to maintain loyalty. Cutting service may backfire as customers prioritise seamless, personalized interactions. Whether tariffs remain or serve as a negotiation tool, companies that invest in strong customer experiences will retain market share and stay competitive.
Boots faces new ownership and uncertain future in $10bn deal
US pharmacy giant Walgreens is being taken private in a $10bn deal by Sycamore Partners, raising fresh uncertainty for Boots and its 50,000 UK employees. Sycamore plans to retain Walgreens’ US retail operations while potentially selling or spinning off Boots. Walgreens had previously attempted to sell Boots in 2022 but failed to secure buyers.
While Boots has improved its pricing and beauty offerings, analysts warn UK retail struggles could make a sale difficult. Experts suggest an IPO may get delayed until late 2025 as Sycamore finalises its acquisition and evaluates future options for the iconic UK pharmacy chain.